- Advinus discovers novel molecule for treatment of diabetes, ...
- Advinus sees diabetes molecule breakthrough in six months...
- Advinus Therapeutics Achieves Milestone in Drug Discovery an...

Clinical Pharmacology
Advinus does not currently conduct clinical research in house. For clinical capability Advinus has established a strategic partnership with Veeda-CR, a full-service Clinical CRO (BA/BE, Phase I – IV & Data Management) with global operations in England, India and Belgium. This alliance allows Advinus to extend its Drug Development capabilities to humans, and leverages Veeda's biomarkers capabilities for preclinical and clinical applications.
The integrated approach to Drug Development creates value for our Pharma and Biotech customers through packages involving preclinical and early clinical development, animal and human safety pharmacology, preclinical toxicology and pharmacology, clinical pharmacology as also microdosing capabilities to pick drug candidates on the basis of human PK data.
The integrated approach to Drug Development creates value for our Pharma and Biotech customers through packages involving preclinical and early clinical development, animal and human safety pharmacology, preclinical toxicology and pharmacology, clinical pharmacology as also microdosing capabilities to pick drug candidates on the basis of human PK data.

